@Delta you can’t find one more pilot to fly tonight from your HQ city Atlanta? You cancel our flight at 1130pm? Thanks for the huge inconvenience for the full flight. #bogus
NEW: The Trump administration and Pfizer have reached a deal to supply an additional 100 million doses of the Pfizer-BioNTech vaccine for the U.S. by the end of July, bringing the total to 200 million doses that will vaccinate 100 million Americans. https://t.co/twaXPHiRnX
UPDATE: The @MHRAgovuk issued a temporary authorization for emergency use of our #COVID19 vaccine with @BioNTech_Group in the United Kingdom.
This marks the first authorization of a vaccine to help fight the pandemic following a worldwide trial.
#COVID19 UPDATE: We will submit a request today to the @US_FDA for Emergency Use Authorization (EUA) of our mRNA vaccine candidate with @BioNTech_Group.
UPDATE: We are proud to announce, along with @BioNTech_Group, that our mRNA-based #vaccine candidate has, at an interim analysis, demonstrated initial evidence of efficacy against #COVID19 in participants without prior evidence of SARS-CoV-2 infection.
“Ensuring over a billion people globally have access to our potential vaccine is as critical as developing the vaccine itself.” See how Pfizer is preparing to deliver up to 100 million doses of a #COVID19 vaccine this year and another 1.3 billion in 2021. https://t.co/RWmKyIwHB9
Watch @AlbertBourla, Pfizer’s CEO, speak about the pledge commitment we’ve made with other pharmaceutical companies to uphold the integrity of the scientific progress as we work towards a #COVID19 vaccine. https://t.co/l9907V5e9J
We have committed to developing our #COVID19 vaccine candidate with unprecedented speed, without sacrificing safety. Hear from our Chief Medical Officer Dr. Mace Rothenberg what that means and the progress we have made: https://t.co/sp9NQw7FYq
Pfizer and BioNTech are leveraging decades of scientific expertise and working together to develop, test and manufacture a potential mRNA vaccine to help prevent COVID-19.
We’ve reached a new milestone in our #COVID19 clinical trial: we’re more than 50% of our goal to enroll up to 30,000 volunteers in our trial for an investigational #vaccine.